| Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease DM Good, P Zürbig, A Argiles, HW Bauer, G Behrens, JJ Coon, M Dakna, ... Molecular & cellular proteomics 9 (11), 2424-2437, 2010 | 547 | 2010 |
| Progression of nephropathy in type 2 diabetic patients K Rossing, PK Christensen, P Hovind, L Tarnow, P Rossing, HH Parving Kidney international 66 (4), 1596-1605, 2004 | 493 | 2004 |
| Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes P Hovind, L Tarnow, K Rossing, P Rossing, S Eising, N Larsen, C Binder, ... Diabetes care 26 (4), 1258-1264, 2003 | 455 | 2003 |
| Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study K Rossing, KJ Schjoedt, UM Smidt, F Boomsma, HH Parving Diabetes care 28 (9), 2106-2112, 2005 | 366 | 2005 |
| Clinical proteomics: a need to define the field and to begin to set adequate standards H Mischak, R Apweiler, RE Banks, M Conaway, J Coon, A Dominiczak, ... PROTEOMICS–Clinical Applications 1 (2), 148-156, 2007 | 360 | 2007 |
| Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy P Jacobsen, S Andersen, K Rossing, BR Jensen, HH Parving Kidney international 63 (5), 1874-1880, 2003 | 352 | 2003 |
| Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial K Rossing, P Jacobsen, L Pietraszek, HH Parving Diabetes care 26 (8), 2268-2274, 2003 | 341 | 2003 |
| Urinary proteomics in diabetes and CKD K Rossing, H Mischak, M Dakna, P Zürbig, J Novak, BA Julian, DM Good, ... Journal of the American Society of Nephrology 19 (7), 1283-1290, 2008 | 330 | 2008 |
| Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria K Rossing, KJ Schjoedt, BR Jensen, F Boomsma, HH Parving Kidney international 68 (3), 1190-1198, 2005 | 319 | 2005 |
| Beneficial impact of spironolactone in diabetic nephropathy KJ Schjoedt, K Rossing, TR Juhl, F Boomsma, P Rossing, L Tarnow, ... Kidney international 68 (6), 2829-2836, 2005 | 296 | 2005 |
| Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study K Rossing, PK Christensen, BR Jensen, HH Parving Diabetes care 25 (1), 95-100, 2002 | 278 | 2002 |
| Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease J Jantos-Siwy, E Schiffer, K Brand, G Schumann, K Rossing, C Delles, ... Journal of proteome research 8 (1), 268-281, 2009 | 275 | 2009 |
| Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy KJ Schjoedt, K Rossing, TR Juhl, F Boomsma, L Tarnow, P Rossing, ... Kidney international 70 (3), 536-542, 2006 | 268 | 2006 |
| CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics JJ Coon, P Zürbig, M Dakna, AF Dominiczak, S Decramer, D Fliser, ... Proteomics–Clinical Applications 2 (7‐8), 964-973, 2008 | 246 | 2008 |
| Plasma concentrations of VCAM‐1 and ICAM‐1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy P Clausen, P Jacobsen, K Rossing, JS Jensen, HH Parving, ... Diabetic Medicine 17 (9), 644-649, 2000 | 215 | 2000 |
| Unchanged incidence of diabetic nephropathy in IDDM patients P Rossing, K Rossing, P Jacobsen, HH Parving Diabetes 44 (7), 739-743, 1995 | 210 | 1995 |
| Dual blockade of the renin–angiotensin system in type 1 patients with diabetic nephropathy P Jacobsen, S Andersen, K Rossing, BV Hansen, HH Parving Nephrology Dialysis Transplantation 17 (6), 1019-1024, 2002 | 189 | 2002 |
| Pregnancy and progression of diabetic nephropathy K Rossing, P Jacobsen, E Hommel, E Mathiesen, A Svenningsen, ... Diabetologia 45, 36-41, 2002 | 179 | 2002 |
| Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns K Rossing, H Mischak, HH Parving, PK Christensen, M Walden, ... Kidney international 68 (1), 193-205, 2005 | 158 | 2005 |
| Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy P Jacobsen, K Rossing, P Rossing, L Tarnow, C Mallet, O Poirier, ... Kidney international 53 (4), 1002-1006, 1998 | 149 | 1998 |
Peter RossingSteno Diabetes CenterBestätigte E-Mail-Adresse bei dadlnet.dk
